Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001012975-06-000056
Filing Date
2006-02-10
Accepted
2006-02-10 16:07:38
Documents
1
Group Members
ALAN G. WALTONJEFFREY T. BARNESJONATHAN J. FLEMINGMARK P. CARTHYMICHAEL E. LYTTONMRNA FUND II L.P.OBP MANAGEMENT IV L.P.

Document Format Files

Seq Description Document Type Size
1 e8302443.txt SC 13D/A 10488
  Complete submission text file 0001012975-06-000056.txt   12598
Mailing Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545
Business Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545 5106709300
Solexa, Inc. (Subject) CIK: 0000913275 (see all company filings)

EIN.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45671 | Film No.: 06598703
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address
Business Address 222 BERKELEY STREET SUITE 1650 BOSTON MA 02116 6173577474
OXFORD BIOSCIENCE PARTNERS IV LP (Filed by) CIK: 0001140484 (see all company filings)

EIN.: 043556435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A